Skip to content

Your donation DOUBLED through April 30 thanks to anonymous donors who pledged to match your gift!   DONATE NOW!

Further Development and Validation of the Cerebellar Neuropsychiatric Rating Scale (CNRS)

Further Development and Validation of the Cerebellar Neuropsychiatric Rating Scale (CNRS)

There are many scales that assess the disruption of drive, motivation, mood, impulsivity, anxiety, and social cognition, in patients with psychiatric illness. However, no single scale covers the issues that we have identified in the cerebellar patient population. There is not a scale to assess the emotional component of the Cerebellar Cognitive Affective Syndrome (CCAS), and this highlights a lack a sensitivity of current exams regarding patients with cerebellar disorders.

We aim to further validate a neuropsychiatric rating scale that is sensitive to the neuropsychiatric issues experienced by patients with injuries or degenerations involving the cerebellum.

Link to Enroll: https://redcap.partners.org/redcap/surveys/?s=XCKPAH977ETHAMTJ

About the Study

Eligible Ataxia Types
Spinocerebellar Ataxias (All Types)

Type of Study
Survey

Clinical Trial Phase
N/A

Age Range
Adult 18+

Study Start Date
07/08/2021

Estimated Completion Date
07/01/2026

IRB Approval #
2021P000808

Location(s)

Online study

Massachusetts General Hospital
101 Merrimac Street, Suite 300
Boston, MA

Contact Information

Anna Burt
aburt2@mgh.harvard.edu
617-726-2476

What does participation in the study entail?

We will ask you to complete an online survey and brief clinical information and demographics forms. Total time should be about 10-15 minutes.

What are the potential benefits for participants?

There are no direct benefits to participants, however there are expected benefits to science that include a detailed understanding of how best to test for neuropsychiatric problems in cerebellar diseases in a clinical setting. 

What are the potential risks for participants?

There are no clear risks associated with neuropsychiatric testing. You may experience some anxiety while filling out the scale. 

Is there financial compensation?

No.

Is there travel reimbursement?

No.

Who is eligible?

We are looking to study people who are 18 years old and above, who are diagnosed with ataxia and are English-speaking. This is a new study. We invite you to participate, even if you have already participated in an earlier version of this study. 

Additional Information or Resources

View Other Research Opportunities

There are many scales that assess the disruption of drive, motivation, mood, impulsivity, anxiety, and social cognition, in patients with psychiatric illness. However, no single scale covers the issues that we have identified in the cerebellar patient population. There is not a scale to assess the emotional component of the Cerebellar Cognitive Affective Syndrome (CCAS), and this highlights a lack a sensitivity of current exams regarding patients with cerebellar disorders.

We aim to further validate a neuropsychiatric rating scale that is sensitive to the neuropsychiatric issues experienced by patients with injuries or degenerations involving the cerebellum.

Link to Enroll: https://redcap.partners.org/redcap/surveys/?s=XCKPAH977ETHAMTJ

About the Study

Eligible Ataxia Types
Spinocerebellar Ataxias (All Types)

Type of Study
Survey

Clinical Trial Phase
N/A

Age Range
Adult 18+

Study Start Date
07/08/2021

Estimated Completion Date
07/01/2026

IRB Approval #
2021P000808

Location(s)

Online study

Massachusetts General Hospital
101 Merrimac Street, Suite 300
Boston, MA

Contact Information

Anna Burt
aburt2@mgh.harvard.edu
617-726-2476

What does participation in the study entail?

We will ask you to complete an online survey and brief clinical information and demographics forms. Total time should be about 10-15 minutes.

What are the potential benefits for participants?

There are no direct benefits to participants, however there are expected benefits to science that include a detailed understanding of how best to test for neuropsychiatric problems in cerebellar diseases in a clinical setting. 

What are the potential risks for participants?

There are no clear risks associated with neuropsychiatric testing. You may experience some anxiety while filling out the scale. 

Is there financial compensation?

No.

Is there travel reimbursement?

No.

Who is eligible?

We are looking to study people who are 18 years old and above, who are diagnosed with ataxia and are English-speaking. This is a new study. We invite you to participate, even if you have already participated in an earlier version of this study. 

Additional Information or Resources

View Other Research Opportunities

Print Friendly, PDF & Email
Translate »

Join the Ataxia community today!

Become a free member for exclusive content from NAF.